Vistin Pharma ASA: Invitation to Q1 2022 conference call

Oslo, Norway, 20 April 2022

Vistin Pharma ASA will release its first quarter 2022 results on Wednesday 27^th of April 2022. Vistin Pharma will host a conference call for all shareholders and interested parties on Wednesday 27^th of April at 08:30 CET. There will be a Q&A session following the management discussion.

The conference call will be held in English.

The first quarter conference call will be available via web and audio through the following access points:

Telephone conference:
Confirmation Code:           8168697
International dial-In:         +44 (0) 2071 928338
Norway, Oslo:                   +47 21563015
United States, New York:   +1 6467413167

Webcast:
https://edge.media-server.com/mmc/p/s56tfz7e

*****

For further information, please contact:

Alexander Karlsen
CFO
+47 97053621
alexander.karlsen@vistin.com

About Vistin Pharma | www.vistin.com

Vistin Pharma is a Norwegian pharmaceutical company producing Metformin Hydrochloride (API). The Metformin is also available as Direct Compressible lubricated granules. As a solely dedicated European Metformin producer, Vistin Pharma is a well–positioned supplier to leading pharmaceutical companies. Vistin Pharma is headquartered in Oslo, Norway, and has highly qualified employees and a dedicated manufacturing facility in Kragerø.